Previous 10 | Next 10 |
home / stock / emhtf / emhtf news
Through the end of the first quarter, cannabis had been the hottest investment on Wall Street . Over the past three-plus years, most pot stocks had risen by a triple-digit or quadruple-digit percentage, with lofty sales expectations fueling this surge in valuations. However, the past seven-plu...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), has entered into a binding term sheet with a si...
VANCOUVER, British Columbia, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has received organic certification for cannabis production at its Metro Vancouver operation in British Columbia, which encompasses 156,000 squ...
VANCOUVER, British Columbia, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has signed an agreement to become a new supplier to STENOCARE A/S (“STENOCARE”) of medical cannabis for Denmark and STENOCARE...
Welcome to our Weekly Cannabis Report, a reliable source for investors to receive the latest developments and analysis in the cannabis sector. Trading Summary Cannabis stocks resumed sell-off last week. The Horizons Marijuana Life Sciences Index ETF ( HMLSF ) lost 5.4%, the ETFMG Alternati...
VANCOUVER, British Columbia, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) will participate in the Cowen 2 nd Annual Boston Cannabis Conference being held on November 12 th and 13 th , 2019, at the InterContinental ...
VANCOUVER, British Columbia, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has announced an internal reorganization including the reduction of its workforce and other expenditures. It is at the same time reinforcing i...
VANCOUVER, British Columbia, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has fulfilled its first shipment of premium cannabis products to the Nova Scotia Liquor Corporation (NSLC) for the adult-use market. This firs...
During the past trading week (October 14 to 18), the second stage of cannabis legalization in Canada kicked off with the introduction of edibles and other ingestible products. The Investing News Network covered the stock market’s reaction to this new phase for the industry, while othe...
Legalization 2.0 is here! The cannabis market is about to receive a massive influx of cannabis derivative products, such as vapes, edibles, and infused drinks, to name just a few. You can expect to see these hit shelves across Canada by mid-December, once the necessary paperwork is proces...
News, Short Squeeze, Breakout and More Instantly...
Emerald Health Therapeutics Company Name:
EMHTF Stock Symbol:
OTCMKTS Market:
Emerald Health Therapeutics Website:
Emerald Health Therapeutics Inc (EMHTF) is expected to report for Q3 2022
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") announced today that its Plan of Arrangement with Skye Bioscience, Inc. ("Skye") has closed and that it has entered into agreements to di...
Skye will continue to pursue Canadian Securities Exchange listing following closing of transaction Vancouver, British Columbia--(Newsfile Corp. - November 7, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") and Skye Bioscience, Inc. (OTCQB: SKYE...